Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T70144 |
ORP-101
|
||
ORP-101 is a new chemical entity designed with intent to create a large stable molecule and to confer partial μ agonist and full κ-antagonist receptor pharmacology. | |||
T70143 |
Derazantinib dihydrochloride
|
||
Derazantinib is a multi-kinase inhibitor with pan-FGFR activity which has shown preliminary therapeutic activity against FGFR2 fusion-positive intrahepatic cholangiocarcinoma (iCCA). Derazantinib dihydrochloride is a salt of Derazantinib. |